D.E. Shaw & Co’s Diebold Nixdorf Incorporated DBD Stock Holding History

D.E. Shaw & Co’s Portfolio DBD Stock Details DBD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-75,000	Closed	-$338K	–	4076
2018 Q3	$338K	Sell	75,000 -26,000	-26%	-$190K	﹤0.01%	3311
2018 Q2	$1.21M	Buy	+101,000	New	+$1.35M	﹤0.01%	2578
2017 Q2	–	Sell	-49,700	Closed	-$1.53M	–	3594
2017 Q1	$1.53M	Sell	49,700 -24,600	-33%	-$695K	﹤0.01%	2026
2016 Q4	$1.87M	Buy	74,300 +29,700	+67%	+$700K	﹤0.01%	2044
2016 Q3	$1.11M	Buy	+44,600	New	+$1.18M	﹤0.01%	2327

Other funds holding DBD

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $25.5B AUM 28.85% 1-Year Est. Return

BFIM

Beese Fulmer Investment Management Canton, Ohio $1.56B AUM 26.01% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

D.E. Shaw & Co's DBD Position: Q2 2023 in Review

D.E. Shaw & Co sold out of Diebold Nixdorf Incorporated (DBD) in Q2 2023, closing a stake of 683,846 shares — an estimated $821K sold.

D.E. Shaw & Co first reported a position in DBD in Q2 2013 and held it in 36 quarters. The position peaked at $33.1M in Q1 2021. 7 funds tracked by Wall St. Rank hold DBD as of Q2 2023.

D.E. Shaw & Co reported no remaining Diebold Nixdorf Incorporated position as of Q2 2023 after selling out during the quarter.
D.E. Shaw & Co sold 683,846 Diebold Nixdorf Incorporated shares in Q2 2023, an estimated $821K.
D.E. Shaw & Co first reported a position in Diebold Nixdorf Incorporated in Q2 2013 and held it in 36 quarters.
D.E. Shaw & Co's Diebold Nixdorf Incorporated position peaked at $33.1M in Q1 2021.
7 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q2 2023.

Based on D.E. Shaw & Co's 13F filing for Q2 2023, filed 14 Aug 2023.